114 related articles for article (PubMed ID: 17662609)
1. Stereoselective synthesis of beta-1-C-substituted 1,4-dideoxy-1,4-imino-D-galactitols and evaluation as UDP-galactopyranose mutase inhibitors.
Desvergnes S; Desvergnes V; Martin OR; Itoh K; Liu HW; Py S
Bioorg Med Chem; 2007 Oct; 15(19):6443-9. PubMed ID: 17662609
[TBL] [Abstract][Full Text] [Related]
2. Convergent and stereoselective synthesis of iminosugar-containing Galf and UDP-Galf mimicks: evaluation as inhibitors of UDP-Gal mutase.
Liautard V; Desvergnes V; Itoh K; Liu HW; Martin OR
J Org Chem; 2008 Apr; 73(8):3103-15. PubMed ID: 18358048
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel ammonium and selenonium ions and their evaluation as inhibitors of UDP-galactopyranose mutase.
Veerapen N; Yuan Y; Sanders DA; Pinto BM
Carbohydr Res; 2004 Sep; 339(13):2205-17. PubMed ID: 15337448
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective synthesis of alpha-C-Substituted 1,4-dideoxy-1,4-imino-D-galactitols. Toward original UDP-Galf mimics via cross-metathesis.
Liautard V; Desvergnes V; Martin OR
Org Lett; 2006 Mar; 8(7):1299-302. PubMed ID: 16562876
[TBL] [Abstract][Full Text] [Related]
5. Diastereoselective synthesis of novel iminosugar-containing UDP-Galf mimics: potential inhibitors of UDP-Gal mutase and UDP-Galf transferases.
Liautard V; Christina AE; Desvergnes V; Martin OR
J Org Chem; 2006 Sep; 71(19):7337-45. PubMed ID: 16958528
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM).
Kuppala R; Borrelli S; Slowski K; Sanders DA; Ravindranathan Kartha KP; Pinto BM
Bioorg Med Chem Lett; 2015 May; 25(9):1995-7. PubMed ID: 25819094
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric routes toward polyhydroxylated pyrrolidines: Synthesis of 1,4-dideoxy-1,4-imino-d-galactitol and 1,4-dideoxy-1,4-imino-d-glucitol.
Righi G; Mandic' E; Sappino C; Dema E; Bovicelli P
Carbohydr Res; 2016 Nov; 435():100-105. PubMed ID: 27736666
[TBL] [Abstract][Full Text] [Related]
8. Reversible and efficient inhibition of UDP-galactopyranose mutase by electrophilic, constrained and unsaturated UDP-galactitol analogues.
Ansiaux C; N'Go I; Vincent SP
Chemistry; 2012 Nov; 18(46):14860-6. PubMed ID: 23015271
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a novel class of sulfonium ions as potential inhibitors of UDP-galactopyranose mutase.
Ghavami A; Chen JJ; Mario Pinto B
Carbohydr Res; 2004 Jan; 339(2):401-7. PubMed ID: 14698899
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.
Dykhuizen EC; May JF; Tongpenyai A; Kiessling LL
J Am Chem Soc; 2008 May; 130(21):6706-7. PubMed ID: 18447352
[TBL] [Abstract][Full Text] [Related]
11. Drug targeting Mycobacterium tuberculosis cell wall synthesis: development of a microtiter plate-based screen for UDP-galactopyranose mutase and identification of an inhibitor from a uridine-based library.
Scherman MS; Winans KA; Stern RJ; Jones V; Bertozzi CR; McNeil MR
Antimicrob Agents Chemother; 2003 Jan; 47(1):378-82. PubMed ID: 12499218
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic investigation of UDP-galactopyranose mutase from Escherichia coli using 2- and 3-fluorinated UDP-galactofuranose as probes.
Zhang Q; Liu H
J Am Chem Soc; 2001 Jul; 123(28):6756-66. PubMed ID: 11448178
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a novel UDP-carbasugar as UDP-galactopyranose mutase inhibitor.
El Bkassiny S; N'Go I; Sevrain CM; Tikad A; Vincent SP
Org Lett; 2014 May; 16(9):2462-5. PubMed ID: 24746099
[TBL] [Abstract][Full Text] [Related]
14. Identification of inhibitors for UDP-galactopyranose mutase.
Soltero-Higgin M; Carlson EE; Phillips JH; Kiessling LL
J Am Chem Soc; 2004 Sep; 126(34):10532-3. PubMed ID: 15327298
[TBL] [Abstract][Full Text] [Related]
15. Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite.
Dykhuizen EC; Kiessling LL
Org Lett; 2009 Jan; 11(1):193-6. PubMed ID: 19067595
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.
van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA
J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.
Caravano A; Mengin-Lecreulx D; Brondello JM; Vincent SP; Sinaÿ P
Chemistry; 2003 Dec; 9(23):5888-98. PubMed ID: 14673861
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Enantiomeric Polyhydroxyalkylpyrrolidines from 1,3-Dipolar Cycloadducts. Evaluation as Inhibitors of a β-Galactofuranosidase.
Oliveira Udry GA; Repetto E; Vega DR; Varela O
J Org Chem; 2016 May; 81(10):4179-89. PubMed ID: 27116655
[TBL] [Abstract][Full Text] [Related]
20. UDP-galactopyranose mutase has a novel structure and mechanism.
Sanders DA; Staines AG; McMahon SA; McNeil MR; Whitfield C; Naismith JH
Nat Struct Biol; 2001 Oct; 8(10):858-63. PubMed ID: 11573090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
